SLC52A3 and cancer: As for the cancer risk, riboflavin supplement was thought to reduce various types of cancer risks,13 and several cancer risk research found that SLC52A3 SNPs was associated with oesophageal cancer risk,14, 15, 16 probably activated by NF‐κB p65/Rel‐B.17